Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL106465 | 0.83 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL3342253 | 0.79 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL31462921 | 0.79 | CA12 (0.35) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL1076760 | 0.78 | HCAR2 (0.38) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL102165 | 0.74 | — | — | |
| SCHEMBL10412335 | 0.74 | MAPT (0.47) | ALDH1A1HCAR2TSHRNPSR1MAPT | |
| SCHEMBL102982 | 0.73 | — | — | |
| SCHEMBL758863 | 0.70 | KMT2A (0.48) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL8279963 | 0.70 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL5024897 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | disclosed |
| US-12330394-B2 | Laminate and image display device | FUJIFILM CORPORATION (JP) | 2025-06-17 | — | — | US | disclosed |
| US-20250163241-A1 | ACTIVE ENERGY RAY-CURABLE RESIN COMPOSITION, CURED PRODUCT, LAMINATE ,AND ARTICLE | DIC CORPORATION (JP) | 2025-05-22 | — | — | US | disclosed |
| WO-2025086244-A1 | METHOD FOR IMPROVING DISEASE AND PEST RESISTANCE OF COTTON | 新疆新晨农业发展有限公司 | 2025-05-01 | — | — | WO | disclosed |
| CN-119899862-A | Method for improving disease and pest resistance of cotton | 新疆新晨农业发展有限公司 | 2025-04-29 | — | — | CN | disclosed |
| US-20250082662-A1 | COMPOSITION FOR TREATING BLOOD CANCER USING 4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND USES THEREOF | SOUTHERN RES INST (US) | 2025-03-13 | — | — | US | disclosed |
| WO-2025052975-A1 | OPTICAL FILM, OPTICAL LAMINATE, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | 富士フイルム株式会社 | 2025-03-13 | — | — | WO | disclosed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | disclosed |
| US-20250043053-A1 | ACTIVE ENERGY RAY-CURABLE RESIN COMPOSITION, CURED PRODUCT, LAMINATE, AND ARTICLE | DIC CORPORATION (JP) | 2025-02-06 | — | — | US | disclosed |
| US-12208112-B2 | Composition for treating blood cancer using 4′-thio-5-Aza-2′-deoxycytidine and uses thereof | SOUTHERN RESEARCH INSTITUTE (US) | 2025-01-28 | — | — | US | disclosed |
| US-20080145861-A1 | Methods of protein production in cell lines | AVIGENICS, INC. | 2008-06-19 | — | — | US | disclosed |
| EP-1903873-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | THE UNIVERSITY OF ROCHESTER (US) | 2008-04-02 | — | — | EP | disclosed |
| US-7351582-B2 | Cell lines | AVIGENICS, INC. (US) | 2008-04-01 | — | — | US | disclosed |
| US-20080070303-A1 | Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement | ADVANCED CELL TECHNOLOGY | 2008-03-20 | — | — | US | disclosed |
| WO-2007062198-A1 | METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY | ADVANCED CELL TECHNOLOGY, INC. (US) | 2007-05-31 | — | — | WO | disclosed |
| US-20060286638-A1 | Cell lines | AVIGENICS, INC. | 2006-12-21 | — | — | US | disclosed |
| WO-2006135602-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | UNIVERSITY OF ROCHESTER (US) | 2006-12-21 | — | — | WO | disclosed |
| US-20050090001-A1 | Cell lines and methods for producing proteins | SYNAGEVA BIOPHARMA CORP. | 2005-04-28 | — | — | US | disclosed |
| US-5602284-A | TREATING DIPHENYLAMINE WITH DOUBLE-BONDED OXYGEN COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1997-02-11 | — | — | US | disclosed |
| EP-0701996-A1 | Process for the separation of aminodiphenyl from diphenylamine | BAYER AG (DE) | 1996-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12208112-B2 | Composition for treating blood cancer using 4′-thio-5-Aza-2′-deoxycytidine and uses thereof | DCTD, TET3, TET1 | ALDH1A1 1015/4885LMNA 4367/4885HSD17B10 3159/4885 |
| US-20250082662-A1 | COMPOSITION FOR TREATING BLOOD CANCER USING 4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND USES THEREOF | DCTD, TET3, TET1 | ALDH1A1 1107/4885LMNA 4390/4885HSD17B10 3150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.